ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Beigene Ltd (PK)

Beigene Ltd (PK) (BEIGF)

15,14
0,00
(0,00%)
Fermé 02 Mars 10:00PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
15,14
Prix Achat
0,0001
Prix Vente
22,04
Volume échangé
-
0,00 Fourchette du Jour 0,00
11,00 Plage de 52 semaines 15,50
Cap du marché
Clôture Veille
15,14
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
119
Actions en circulation
1 353 730 830
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-23,25
Bénéfice par action (BPA)
-0,65
Chiffre d'affairess
2,46B
Bénéfice net
-881,71M

À propos de Beigene Ltd (PK)

We are a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. Our internally-developed lead drug candidates are currently in late-stage clinical trials, including 21 registration or reg... We are a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer. Our internally-developed lead drug candidates are currently in late-stage clinical trials, including 21 registration or registration-enabling trials in 14 discrete cancer indications. We have submitted three new drug applications for regulatory approval in China and are planning for new drug launches and additional submissions in China and the United States in 2019 and 2020. In addition, we are marketing three in-licensed cancer drugs in China from which we have been generating product revenue since September 2017. We started as a research and development company in Beijing in 2010, focusing on developing best-in-class oncology drugs. Over the last nine years, we have developed into a fully-integrated global biotechnology company with operations in China, the United States, Europe and Australia, including a more than 800-person global clinical development team running over 50 ongoing or planned clinical trials as of January 24, 2019. We also have a growing commercial team that is selling our existing in-licensed drugs in China and preparing for launches of our internally-developed drug candidates in China and the United States, as well as internal manufacturing capabilities in China that are operational or under construction for the clinical and commercial supply of our small molecule and biologic drug candidates. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Grand Cayman, Cym
Fondé
-
Beigene Ltd (PK) est coté dans le secteur Pharmaceutical Preparations de la OTCMarkets avec le ticker BEIGF. Le dernier cours de clôture d'Beigene (PK) était de US$15,14. Au cours de la dernière année, les actions de Beigene (PK) ont été négociées dans une fourchette de prix de US$ 11,00 à US$ 15,50.

Beigene (PK) compte actuellement 1 353 730 830 actions en circulation. La capitalisation boursière d'Beigene (PK) est de US$20,50 milliard. Beigene (PK) a un ratio cours/bénéfice (ratio PE) de -23.25.

BEIGF Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120.745.1388888888914.415.1413.67511914.23555789CS
26-0.36-2.3225806451615.515.513.67510514.68284354CS
523.8634.21985815611.2815.51111913.66598204CS
156-1.56-9.3413173652716.716.781139114.47197863CS
260-5.0336-24.9514216620.173629.2541112732425.93119743CS

BEIGF - Frequently Asked Questions (FAQ)

What is the current Beigene (PK) share price?
The current share price of Beigene (PK) is US$ 15,14
How many Beigene (PK) shares are in issue?
Beigene (PK) has 1 353 730 830 shares in issue
What is the market cap of Beigene (PK)?
The market capitalisation of Beigene (PK) is USD 20,5B
What is the 1 year trading range for Beigene (PK) share price?
Beigene (PK) has traded in the range of US$ 11,00 to US$ 15,50 during the past year
What is the PE ratio of Beigene (PK)?
The price to earnings ratio of Beigene (PK) is -23,25
What is the cash to sales ratio of Beigene (PK)?
The cash to sales ratio of Beigene (PK) is 8,34
What is the reporting currency for Beigene (PK)?
Beigene (PK) reports financial results in USD
What is the latest annual turnover for Beigene (PK)?
The latest annual turnover of Beigene (PK) is USD 2,46B
What is the latest annual profit for Beigene (PK)?
The latest annual profit of Beigene (PK) is USD -881,71M
What is the registered address of Beigene (PK)?
The registered address for Beigene (PK) is 94 SOLARIS AVENUE, CAMANA BAY, PO BOX 1348, GRAND CAYMAN, KY1 1104
What is the Beigene (PK) website address?
The website address for Beigene (PK) is www.beigene.com
Which industry sector does Beigene (PK) operate in?
Beigene (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
STTOSITO Mobile Ltd (CE)
US$ 0,02
(1 999 900,00%)
278
NLVVFNew Leaf Ventures (CE)
US$ 0,0089
(889 900,00%)
6,92k
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0,008
(799 900,00%)
101
ETBIEastgate Biotech Corporation (CE)
US$ 0,0045
(449 900,00%)
2k
VWESQVintage Wine Estates Inc (CE)
US$ 0,002
(199 900,00%)
3,44k
NEXINexImmune Inc (CE)
US$ 0,0001
(-99,90%)
13,59k
JERTQJER Investors Trust Inc New (CE)
US$ 0,000001
(-99,67%)
10k
AGILQAgileThought Inc (CE)
US$ 0,0001
(-99,10%)
4,7k
GAYGFMontauk Metals Inc (PK)
US$ 0,0012
(-99,08%)
6,25k
IONMAssure Holdings Corporation (CE)
US$ 0,000001
(-99,00%)
112
HMBLHUMBL Inc (PK)
US$ 0,0005
(25,00%)
279,83M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0,0026
(-3,70%)
123,47M
SPQSSportsQuest Inc (PK)
US$ 0,0001
(-50,00%)
114,57M
BOMObowmo Inc (PK)
US$ 0,0001
(0,00%)
102,85M
VTXBVortex Brands Company (PK)
US$ 0,0001
(0,00%)
101,18M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock